Kevin Fitzpatrick has been named Chief Executive Officer (CEO) of CancerLinQ LLC, a wholly owned non-profit subsidiary of the American Society of Clinical Oncology (ASCO). Mr. Fitzpatrick, who is currently the Executive Vice President and Chief Innovation Officer of the American College of Cardiology (ACC), will begin his new role on August 3.
CHICAGO – The American Society of Clinical Oncology’s (ASCO) wholly owned non-profit subsidiary, CancerLinQ LLC, will provide the first demonstration of its groundbreaking health information technology (HIT) platform at ASCO’s 51st Annual Meeting.
ALEXANDRIA, VA – The American Society of Clinical Oncology (ASCO) today announced that its wholly owned subsidiary, CancerLinQ LLC, will use the SAP HANA® platform in the development of ASCO’s CancerLinQ™. CancerLinQ is a groundbreaking health information technology (HIT) platform that will harness Big Data to deliver high-quality care to patients with cancer. It is one of the only major cancer data initiatives being developed and led by physicians with the primary purpose of improving patient care.
Robert S. Miller, MD, FACP, FASCO, Assistant Professor of Oncology and Oncology Medical Information Officer at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, has been named Medical Director of the Institute for Quality (iQ) of the American Society of Clinical Oncology (ASCO).
The Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) has received a major commitment of support for the development of CancerLinQ™ from Cancer Treatment Centers of America, Inc. (CTCA), a national network of five cancer hospitals.
ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) and the Lance Armstrong Foundation today announced the launch of a new video series for young adults with cancer that is featured on ASCO’s patient information website and on the Foundation’s YouTube site. The series, “Moving Forward: Perspectives from Survivors and Doctors,” addresses critical issues that young adults with cancer may face and helps them better understand and cope with challenges related to their diagnosis.